Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia (Q37889846)

24 August 2017

1 reference

title

Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia (English)

1 reference

24 August 2017

1 reference

1 reference

Matteo Giovanni Della Porta

1

1 reference

24 August 2017

Francesco Lanza

2

1 reference

24 August 2017

Luigi Del Vecchio

3

1 reference

24 August 2017

Italian Society of Cytometry (GIC)

4

1 reference

24 August 2017

publication date

14 June 2011

1 reference

Cytometry Part B: Clinical Cytometry

24 August 2017

published in

1 reference

24 August 2017

volume

80

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

201-211

1 reference

Myelodysplastic syndromes--coping with ineffective hematopoiesis

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Unraveling the molecular pathophysiology of myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Identification of RPS14 as a 5q- syndrome gene by RNA interference screen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

The World Health Organization (WHO) classification of the myeloid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Hematopathological concepts and controversies in the diagnosis and classification of myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Myelodysplastic syndrome: a search for minimal diagnostic criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Myelodysplastic syndromes with bone marrow fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Flow cytometric immunophenotyping for hematologic neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Diagnostic flow cytometry for low-grade myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

2006 Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: medical indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Flow cytometric parameters with little interexaminer variability for diagnosing low-grade myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome: correlation to cytomorphology, cytogenetics, and clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: emphasis on a global evaluation and recognition of diagnostic pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Distinct neutrophil subpopulations phenotype by flow cytometry in myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Immunophenotypic clustering of myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Clinical relevance of anemia and transfusion iron overload in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Regulation of ferritin genes and protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

A human mitochondrial ferritin encoded by an intronless gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Clinical implications of blast immunophenotypes in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Diagnostic application of flow cytometric characteristics of CD34+ cells in low-grade myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Reduced CD38 expression on CD34+ cells as a diagnostic test in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

The Specificity of Immunophenotypic Alterations in Blasts in Nonacute Myeloid Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

7 January 2021

Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

7 January 2021

Quantitative assessment of myeloid nuclear differentiation antigen distinguishes myelodysplastic syndrome from normal bone marrow

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

7 January 2021

The utility of flow cytometric immunophenotyping in cytopenic patients with a non-diagnostic bone marrow: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

7 January 2021

WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

7 January 2021

Association between phenotypic features of blasts and the blast percentage in bone marrow of patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

7 January 2021

Aberrant immunophenotype of blasts in myelodysplastic syndromes is a clinically relevant biomarker in predicting response to growth factor treatment

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

7 January 2021

Multiparameter flow cytometric analysis reveals low percentage of bone marrow hematogones in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20607

7 January 2021

Identifiers

DOI

10.1002/CYTO.B.20607

1 reference

release_jmxuubpjbbevrlfubhe7ubwkgy

24 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jmxuubpjbbevrlfubhe7ubwkgy

24 November 2022

mapped directly with Wikidata item

1 reference